Disc Medicine
(NASDAQ) IRON
Disc Medicine Financials at a Glance
Market Cap
$2.66B
Revenue (TTM)
$0.00
Net Income (TTM)
$212.18M
EPS (TTM)
$-5.99
P/E Ratio
-11.64
Dividend
$0.00
Beta (Volatility)
0.92 (Low)
Dividend
$0.00
Beta (Volatility)
0.92 (Low)
Price
$68.88
Volume
3,094
Open
$70.80
Price
$68.88
Volume
3,094
Open
$70.80
Previous Close
$69.71
Daily Range
$68.30 - $70.80
52-Week Range
$40.00 - $99.50
Dividend
$0.00
Beta (Volatility)
0.92 (Low)
Price
$68.88
Volume
3,094
Open
$70.80
Previous Close
$69.71
Daily Range
$68.30 - $70.80
52-Week Range
$40.00 - $99.50
IRON News
IRON: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Disc Medicine
Industry
Biotechnology
Sector
Health CareEmployees
155
CEO
John D. Quisel, PhD
Website
www.discmedicine.comHeadquarters
Watertown, MA 02472, US
IRON Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-36%
Return on Capital
-31%
Return on Assets
-26%
Earnings Yield
-8.59%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.66B
Shares Outstanding
38.16M
Volume
3.09K
Short Interest
0.00%
Avg. Volume
657.69K
Financials (TTM)
Gross Profit
$281.00K
Operating Income
$236.02M
EBITDA
$207.94M
Operating Cash Flow
$180.39M
Capital Expenditure
$933.00K
Free Cash Flow
$181.33M
Cash & ST Invst.
$791.15M
Total Debt
$1.86M
Disc Medicine Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$89.00K
-888.9%
Gross Margin
0.00%
N/A
Market Cap
$2.66B
N/A
Market Cap/Employee
$28.30M
N/A
Employees
94
N/A
Net Income
$60.53M
-105.5%
EBITDA
$58.62M
-342.3%
Quarterly Fundamentals
Net Cash
$789.29M
+71.6%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$1.25M
-95.8%
Short Term Debt
$611.00K
+370.0%
Return on Assets
-26.30%
N/A
Return on Invested Capital
-30.64%
N/A
Free Cash Flow
$43.32M
-54.6%
Operating Cash Flow
$43.30M
-57.0%